Pigmentation treatment product recalled for manufacturing process deviations
Only Your Rx pigmentation product is being recalled due to manufacturing quality deviations in water systems used during production. The product was distributed in California only.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall due to manufacturing process deviations with no reported illnesses or injuries. Per the severity rubric, Class II recalls without hospitalization reports and with theoretical rather than confirmed hazards typically receive a Moderate rating.
Plain-English summary
Only Your Rx Pigmentation Activator is being recalled. The product is manufactured by Generitech Corporation and was distributed in California. The affected lot number is 2400017 with an expiration date of April 30, 2026.
The FDA has issued this Class II recall due to Current Good Manufacturing Practice (CGMP) deviations identified in the water systems used during product manufacturing. No illnesses or injuries have been reported in connection with this product.
Consumers or healthcare professionals who possess this product should contact the manufacturer for instructions regarding return or disposal.
The recalled product
- Product
- 10 Irregular Pigmentation, Accelerator, Pigment Fading Activator, Only Your Rx, Nature + Science, 1 fl. oz., 30 mL Bottle, For Professional Use Only, Only YourRx Inc., Chatsworth, CA 91311, Made in USA, Onlyyourrx.com.
- Manufacturer
- Generitech Corporation
- Category
- Drug — Topical Drug
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2400017
- Exp: 4/30/2026
Distribution
Distributed in 1 state:
- CA
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27